War on Cancer

American Lung Association on World Lung Cancer Day Announces New Patient Resources and Trends Brief

Retrieved on: 
Thursday, July 29, 2021

CHICAGO, July 29, 2021 /PRNewswire/ --In recognition of World Lung Cancer Day, the American Lung Association announced new patient resources and a lung cancer trends brief to further advance support for lung cancer patients and caregivers.

Key Points: 
  • CHICAGO, July 29, 2021 /PRNewswire/ --In recognition of World Lung Cancer Day, the American Lung Association announced new patient resources and a lung cancer trends brief to further advance support for lung cancer patients and caregivers.
  • Lung Cancer Trends Brief: New this year, the Lung Association released this data on lung cancer mortality, incidence, prevalence and other key measures of the burden of this disease.
  • "World Lung Cancer Day presents a meaningful opportunity to highlight our new and existing lung cancer resources that offer support for those impacted by this devastating disease, while building additional awareness across the country," said American Lung Association National President and CEO Harold P. Wimmer.
  • The American Lung Association created LUNG FORCE, a national movement to defeat lung cancer, the leading cancer killer of women and men.

People living with lung cancer launch a social media takeover!

Retrieved on: 
Wednesday, July 28, 2021

Los Angeles, CA, July 28, 2021 (GLOBE NEWSWIRE) -- Join dozens of patient advocates living with lung cancer and meet the researchers working to find better treatments for the disease during a live, 4-hour social media takeover on Facebook, Twitter and Instagram on World Lung Cancer Day, August 1st.

Key Points: 
  • Los Angeles, CA, July 28, 2021 (GLOBE NEWSWIRE) -- Join dozens of patient advocates living with lung cancer and meet the researchers working to find better treatments for the disease during a live, 4-hour social media takeover on Facebook, Twitter and Instagram on World Lung Cancer Day, August 1st.
  • However, lung cancer research is still one of the least funded cancers given that lung cancer kills more people than breast, colon and prostate cancer COMBINED.
  • The World Lung Cancer Day social media takeover is bringing patient advocates and researchers together to advocate and raise funds for increased research funding that helps people living with lung cancer do what they love to do every day.
  • LCFAs mission is the improvement in survivorship of lung cancer patients through the funding of transformative science.

AnPac Bio’s First Disease Treatment Patent Granted, and Its Cancer Treatment Project Secured Multi-Million Dollar Funds

This latest patent is the twenty first patent granted to AnPac Bio in the United States.

Key Points: 
  • This latest patent is the twenty first patent granted to AnPac Bio in the United States.
  • We are pleased that AnPac Bio has been granted our first disease treatment patent, whose disease treatment related claims will be licensed to our new cancer treatment joint venture (while future disease treatment only patent applications will be transferred to the cancer treatment joint venture).
  • We are also pleased that our cancer treatment joint venture has secured funding to speed up its cancer treatment developments.
  • AnPac Bio is a biotechnology company focused on early cancer screening and detection as well as cancer treatment, with 142 issued patents as of March 31, 2021.

FlowPlay Breaks Fundraising Record with Latest Campaign Supporting The American Cancer Society

Retrieved on: 
Monday, June 14, 2021

In partnership with the American Cancer Society ,FlowPlay's campaign raised a record $70,000 in the company'sflagship social casino, Vegas World .

Key Points: 
  • In partnership with the American Cancer Society ,FlowPlay's campaign raised a record $70,000 in the company'sflagship social casino, Vegas World .
  • Funds will support the American Cancer Society's "Get Screened" awareness efforts which encourage people to get their recommended cancer screenings, many of which were delayed due to COVID.
  • "We are extremely grateful to FlowPlay and to Vegas World players for continuing to support our efforts," said Carolyn Williams-Goldman, Interim Executive Vice President West Region, American Cancer Society.
  • The American Cancer Society is a global grassroots force of 1.5 million volunteers dedicated to saving lives, celebrating lives, and leading the fight for a world without cancer.

Cannabics Pharmaceuticals Launches a Breast Cancer Treatment Research Program

Retrieved on: 
Thursday, June 3, 2021

Gabriel Yariv, Cannabics Pharmaceuticals President and COO, said: "We have successfully completed a series of preclinical experiments in our in-house research facilities and have identified promising antitumor results on Breast Cancer cell lines.

Key Points: 
  • Gabriel Yariv, Cannabics Pharmaceuticals President and COO, said: "We have successfully completed a series of preclinical experiments in our in-house research facilities and have identified promising antitumor results on Breast Cancer cell lines.
  • Based on these encouraging results, we now plan further research aimed at developing a new drug candidate for the treatment of Breast Cancer."
  • This Breast Cancer research project is the third cancer treatment project we have launched after Colorectal Cancer and Melanoma, and I expect that additional projects will follow in the near future."
  • Breast cancer is the most common invasive cancer in women, and it is the most commonly diagnosed type of cancer globally along with lung cancer.

National Cancer Survivors Day® 2021 Brings Together Cancer Survivors, Local Communities to Raise Awareness of Survivorship Issues

Retrieved on: 
Wednesday, June 2, 2021

On National Cancer Survivors Day, we want to raise awareness of these challenges of cancer survivorship.

Key Points: 
  • On National Cancer Survivors Day, we want to raise awareness of these challenges of cancer survivorship.
  • The nonprofit National Cancer Survivors Day Foundation offers free guidance, education, networking resources, and assistance to hundreds of hospitals, support groups, and other cancer-related organizations that host official National Cancer Survivors Day celebrations.
  • Join us as we #CelebrateLife and raise awareness of the challenges of cancer survivorship on National Cancer Survivors Day, June 6.
  • #NCSD2021
    The nonprofit National Cancer Survivors Day Foundation offers free guidance, education, networking resources, and assistance to hundreds of hospitals, support groups, and other cancer-related organizations that host National Cancer Survivors Day events in their communities.

Oncotech develops AI-powered real-time mobile cancer screening and detection system

Retrieved on: 
Thursday, May 27, 2021

Developed by Oncotech Nordic AB , Ophtascan is a mobile in-real-time detection system of pre-cancerous and all four levels of cancer conditions and targeted oncological diseases in the human body.

Key Points: 
  • Developed by Oncotech Nordic AB , Ophtascan is a mobile in-real-time detection system of pre-cancerous and all four levels of cancer conditions and targeted oncological diseases in the human body.
  • The process is quick, on demand, cost effective - and does not overload the public health care diagnostic system unnecessarily, hence eliminating patient cancer screening waiting lists.
  • "Conditions currently clinically validated and screened include lung cancer, liver cancer, breast cancer, uterine cancer, and prostate cancer."
  • The Therapeutic R&D and focus is on Diagnostics (mobile in-time cancer screening technology) and cancer treatment Therapies (breast, uterus, lung, prostate, pancreas, liver and neuroblastoma).

Oncotech develops AI-powered real-time mobile cancer screening and detection system

Retrieved on: 
Thursday, May 27, 2021

Developed by Oncotech Nordic AB , Ophtascan is a mobile in-real-time detection system of pre-cancerous and all four levels of cancer conditions and targeted oncological diseases in the human body.

Key Points: 
  • Developed by Oncotech Nordic AB , Ophtascan is a mobile in-real-time detection system of pre-cancerous and all four levels of cancer conditions and targeted oncological diseases in the human body.
  • The process is quick, on demand, cost effective - and does not overload the public health care diagnostic system unnecessarily, hence eliminating patient cancer screening waiting lists.
  • "Conditions currently clinically validated and screened include lung cancer, liver cancer, breast cancer, uterine cancer, and prostate cancer."
  • The Therapeutic R&D and focus is on Diagnostics (mobile in-time cancer screening technology) and cancer treatment Therapies (breast, uterus, lung, prostate, pancreas, liver and neuroblastoma).

American Cancer Society and St. Baldrick's Foundation Award Millions in Research Grants to Fight Childhood Cancer

Retrieved on: 
Friday, May 14, 2021

b'LOS ANGELES, May 14, 2021 /PRNewswire/ -- The American Cancer Society and the St. Baldrick\'s Foundation awarded nearly $3 million to researchers fighting to end childhood cancer.

Key Points: 
  • b'LOS ANGELES, May 14, 2021 /PRNewswire/ -- The American Cancer Society and the St. Baldrick\'s Foundation awarded nearly $3 million to researchers fighting to end childhood cancer.
  • The awards come from a partnership formed between the two organizations in 2019 to provide support for childhood cancer research.
  • These grants will accelerate childhood cancer research with the goals of understanding and discovering new treatment options and improving care and survival in children with cancer.
  • The St. Baldrick\'s Foundation, the largest non-government funder of childhood cancer research grants, is on a mission to give kids a lifetime by supporting the most promising research to find cures and better treatments for all childhood cancers.

Rankings Of Most Common And Deadly Cancer Types Will Shift Over Next Two Decades

Retrieved on: 
Wednesday, April 7, 2021

In conjunction with a substantial decrease in prostate cancer incidence, by 2040 the most common cancer types are estimated to be breast, melanoma, lung, and colorectal.

Key Points: 
  • In conjunction with a substantial decrease in prostate cancer incidence, by 2040 the most common cancer types are estimated to be breast, melanoma, lung, and colorectal.
  • "Our findings reflect the shifting dynamics of cancer screening and treatment," said first study author Lola Rahib, PhD, Director of Scientific and Clinical Affairs at Cancer Commons.
  • "This study underscores the need to invest in screening programs and address healthcare disparities in order to alter the future burden of cancer."
  • "It's time to shift focus to some of the less commonly diagnosed cancers with the lowest survival rates, like pancreatic and liver cancer."